Blood Flow Restriction Study
Launched by STANFORD UNIVERSITY · Apr 30, 2025
Trial Information
Current as of July 04, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, called the Blood Flow Restriction Study, is looking into a new approach to help people with ulnar wrist pain, which is pain on the side of the wrist near the pinky. The goal is to see if a specific type of exercise, combined with a method called blood flow restriction (BFR), can improve strength and reduce pain in patients who have already been wearing a wrist brace for 4 to 6 weeks. Researchers believe that those doing the BFR exercises will report better grip strength and overall improvement compared to those who do not use this method.
To be eligible for this study, participants need to be at least 18 years old and currently receiving therapy for their wrist pain at Stanford Hand Therapy. They should have either recent or ongoing wrist pain that has been treated with immobilization. Participants must also be able to understand the study and give consent. Not everyone can join; for example, those with certain other injuries or who did not follow their brace treatment may not be eligible. If you take part in this study, you can expect to engage in a guided exercise program while being monitored for your progress and any changes in pain or strength.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All patients (\>18 years) undergoing outpatient rehabilitation at Stanford Hand Therapy
- • English fluency and literacy
- • Able to take informed consent
- • Have acute or chronic ulnar-sided wrist pain referred for a course of hand therapy by a physician or advanced practice provider (APP) and were treated with continuous immobilization for 4-6 weeks.
- • Score of 3 or less on blood flow restriction screening questionnaire
- Exclusion Criteria:
- • Concomitant injuries such as upper extremity fractures or other ligamentous injuries
- • TFCC surgery in the affected wrist
- • Non-compliance with immobilization
- • Patients who complete hand therapy at an outside facility
- • Score of 4 or more on blood flow restriction screening questionnaire
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported